February 19, 2019
FDA: Class I recall of Medtronic’s Dual Chamber Implantable Pulse Generators
Editor's Note
The Food & Drug Administration (FDA) on February 15 identified Medtronic, Inc’s (Dublin, Ireland) recall of it’s Dual Chamber Implantable Pulse Generators (IPGs) as Class I, the most serious.
The recall was initiated because of the possibility of a software error that can result in a lack of pacing. A lack of pacing could result in patients experiencing slow heart beating, low blood pressure, light headedness, fainting, and death.
Distribution dates for the IPGs were March 6, 2017 to January 7, 2019.
Free Daily News
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity
- Study finds high rates of preventable, adverse events in perioperative care
- AMA urges stronger radiation protections
- Study: Digital tool detects preoperative pediatric anxiety, depression
- Hospital safety grades show progress in reducing medical errors, infections
- Analysis: Overuse of back surgeries costs Medicare $2 billion, risks patient safety
- AI-powered surgical robot learns by watching
- AHA's Congressional "wish list" calls for financial relief, patient access, workforce protections
- Out-of-hospital cardiac arrest survival rates lag pre-pandemic levels, racial disparities persist
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement